Showing 1131-1140 of 1635 results for "".
- The United Nations Marks World Sight Day with First ‘Blurred’ Photo Exhibitionhttps://modernod.com/news/the-united-nations-marks-world-sight-day-with-first-blurred-photo-exhibition/2481875/As the world prepares to mark World Sight Day on October 12, a
- Prevent Blindness Names Ed Buffington, GPN Technologies, as the 2024 Person of Vision Award Recipienthttps://modernod.com/news/prevent-blindness-names-ed-buffington-gpn-technologies-as-the-2024-person-of-vision-award-recipient/2481856/Prevent Blindness announced that the
- Inventors of OCT Named Winners of 2023 Lasker Awardshttps://modernod.com/news/inventors-of-oct-named-winners-of-2023-lasker-awards/2481841/The
- UC Irvine Researchers Discover a Nanobody that May Lead to Treatment for Retinitis Pigmentosahttps://modernod.com/news/uc-irvine-researchers-discover-a-nanobody-which-may-lead-to-treatment-for-retinitis-pigmentosa/2481805/A team of scientists from the University of California, Irvine, believe they have discovered a special antibody which may lead to a treatment for retinitis pigmentosa. The study,
- Optometry and Vision Science Names New Editor-in-Chiefhttps://modernod.com/news/optometry-and-vision-science-announces-new-editor-in-chief/2481744/The American Academy of Optometry (AAO) announced that David Elliott, PhD, FCOptom, FAAO, is the new editor-in-chief of Optometry and Vision Science (OVS). Mr. Elliott succeeds Michael Twa, OD, PhD, FAAO, who is stepping down from the role after 7 years.
- Dean Burns Named President and CEO of Ocumeticshttps://modernod.com/news/dean-burns-named-president-and-ceo-of-ocumetics/2481722/Ocumetics Technology has appointed ophthalmic executive Dean Burns as President and CEO. Mr. Burns, whoj will also join the Ocumetics board of directors, was previously a consultant for Ocumetics, assisting with regulatory and marketing endeavours. Mr. Burns replaces 
- Jay S. Duker, MD, Named President and CEO of Eyepoint Pharmaceuticalshttps://modernod.com/news/jay-s-duker-md-named-ceo-of-eyepoint-pharmaceuticals/2481715/EyePoint Pharmaceuticals announced the appointment of Jay S. Duker, MD, as President and Chief Executive Officer. Dr. Duker has transitioned from his most recent role as Chief Operating Officer (COO) and President. Dr. Duker has also been appointed to the Board of Di
- Heidelberg Engineering Names Hartmut Becker Head of Global Saleshttps://modernod.com/news/heidelberg-engineering-names-hartmut-becker-head-of-global-sales/2481710/Heidelberg Engineering has introduced Hartmut Becker as new Head of Global Sales, effective April 2023. In his new role, he will be leading the company’s sales and distribution activities across the group, and is responsible for supporting Heidelberg Engineering’s direct sub
- Salvat Laboratories Presents Phase 3 Clinical Trials Results of Clobetasol Nanoemulsion for Treating Inflammation and Pain After Ocular Surgeryhttps://modernod.com/news/salvat-laboratories-presents-phase-3-clinical-trials-results-of-clobetasol-nanoemulsion-for-treating-inflammation-and-pain-after-ocular-surgery/2481604/Salvat Laboratories announced the results of phase 3 clinical trials of its ophthalmic corticosteroid at the Association for Research in Vision and Ophthalmology (ARVO) annual meeting in New Orleans. The studies’ global coordinator, Andrew Schwartz, MD, presented a poster outlinin
- Julie Schornack, OD, Named First Female President of Marshall B. Ketchum Universityhttps://modernod.com/news/julie-schornack-od-named-first-female-president-of-marshall-b-ketchum-university/2481585/Marshall B. Ketchum University (MBKU), an independent, private, non-profit, accredited educational institution in Fullerton, California has introduced Julie A. Schornack, OD, MEd, as its next president to lead the university. Dr. Schornack is the first female p